Ali Murat Kahveci, & Veysel Tahan. (2019). Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies . Turkish Journal of Gastroenterology, 27(1), 89–90. Retrieved from https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/3228
